327 related articles for article (PubMed ID: 11704501)
1. Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake.
Bliziotes MM; Eshleman AJ; Zhang XW; Wiren KM
Bone; 2001 Nov; 29(5):477-86. PubMed ID: 11704501
[TBL] [Abstract][Full Text] [Related]
2. The role of dopamine and serotonin in regulating bone mass and strength: studies on dopamine and serotonin transporter null mice.
Bliziotes M; Gunness M; Eshleman A; Wiren K
J Musculoskelet Neuronal Interact; 2002 Mar; 2(3):291-5. PubMed ID: 15758457
[TBL] [Abstract][Full Text] [Related]
3. Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells.
Bliziotes M; Eshleman A; Burt-Pichat B; Zhang XW; Hashimoto J; Wiren K; Chenu C
Bone; 2006 Dec; 39(6):1313-21. PubMed ID: 16884969
[TBL] [Abstract][Full Text] [Related]
4. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter.
Fabre V; Beaufour C; Evrard A; Rioux A; Hanoun N; Lesch KP; Murphy DL; Lanfumey L; Hamon M; Martres MP
Eur J Neurosci; 2000 Jul; 12(7):2299-310. PubMed ID: 10947809
[TBL] [Abstract][Full Text] [Related]
5. Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences.
Li Q; Wichems C; Heils A; Lesch KP; Murphy DL
J Neurosci; 2000 Nov; 20(21):7888-95. PubMed ID: 11050108
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
Pullar IA; Boot JR; Carney SL; Cohen ML; Colvin EM; Conway RG; Hardy CH; Lucaites VL; Nelson DL; Schenck KW; Tomlinson R; Wedley S
Eur J Pharmacol; 2001 Nov; 432(1):9-17. PubMed ID: 11734182
[TBL] [Abstract][Full Text] [Related]
7. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
[TBL] [Abstract][Full Text] [Related]
8. Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout.
Ase AR; Reader TA; Hen R; Riad M; Descarries L
J Neurochem; 2001 Aug; 78(3):619-30. PubMed ID: 11483665
[TBL] [Abstract][Full Text] [Related]
9. Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT(2A) receptors in adult rat brain.
Moreau X; Jeanningros R; Mazzola-Pomietto P
Neuropsychopharmacology; 2001 Jun; 24(6):652-62. PubMed ID: 11331145
[TBL] [Abstract][Full Text] [Related]
10. Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement.
Sumner BE; Grant KE; Rosie R; Hegele-Hartung C; Fritzemeier KH; Fink G
Brain Res Mol Brain Res; 1999 Nov; 73(1-2):119-28. PubMed ID: 10581405
[TBL] [Abstract][Full Text] [Related]
11. Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity.
Mannoury la Cour C; Boni C; Hanoun N; Lesch KP; Hamon M; Lanfumey L
J Neurosci; 2001 Mar; 21(6):2178-85. PubMed ID: 11245702
[TBL] [Abstract][Full Text] [Related]
12. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization and visualization of the glial serotonin transporter.
Inazu M; Takeda H; Ikoshi H; Sugisawa M; Uchida Y; Matsumiya T
Neurochem Int; 2001 Jul; 39(1):39-49. PubMed ID: 11311448
[TBL] [Abstract][Full Text] [Related]
15. Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate.
Rothman RB; Silverthorn ML; Baumann MH; Goodman CB; Cadet JL; Matecka D; Rice KC; Carroll FI; Wang JB; Uhl GR
J Pharmacol Exp Ther; 1995 Jul; 274(1):385-95. PubMed ID: 7616423
[TBL] [Abstract][Full Text] [Related]
16. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat.
Paczkowski NJ; Vuocolo HE; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):423-30. PubMed ID: 8935709
[TBL] [Abstract][Full Text] [Related]
17. Effects of genetic background on neonatal Borna disease virus infection-induced neurodevelopmental damage. II. Neurochemical alterations and responses to pharmacological treatments.
Pletnikov MV; Rubin SA; Vogel MW; Moran TH; Carbone KM
Brain Res; 2002 Jul; 944(1-2):108-23. PubMed ID: 12106671
[TBL] [Abstract][Full Text] [Related]
18. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin.
Eddahibi S; Fabre V; Boni C; Martres MP; Raffestin B; Hamon M; Adnot S
Circ Res; 1999 Feb; 84(3):329-36. PubMed ID: 10024307
[TBL] [Abstract][Full Text] [Related]
19. Relationship between [125I]RTI-55-labeled cocaine binding sites and the serotonin transporter in rat placenta.
Shearman LP; McReynolds AM; Zhou FC; Meyer JS
Am J Physiol; 1998 Dec; 275(6):C1621-9. PubMed ID: 9843724
[TBL] [Abstract][Full Text] [Related]
20. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.
Béïque JC; Lavoie N; de Montigny C; Debonnel G
Eur J Pharmacol; 1998 May; 349(1):129-32. PubMed ID: 9669506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
